A hand tapping on a laptop next to three pharmaceutical vials

Medical Device Registration (MDR) dossiers Complete documentation packages for Notified Body Opinion applications

Request MDR Dossier

Medical Device Registration dossier packages

In May 2021, the new Medical Device Regulation (MDR) replaced the former Medical Device Directive (MDD) in all countries within the European Union. Even when the principal mode of action is a drug, some containment systems are classified as a medical device part within a Single-Integral Drug Device Combination product (DDC). This classification applies in particular to prefillable syringes and cartridges which are not reusable. In this case, SCHOTT is classified as the “Manufacturer of a critical component of a medical device”. The final holder of the license of the DDC has to apply for a “Notified Body Option” to register the device part (e.g. prefillable syringe) as a medical device.

The General Safety and Performance Requirements (GSPRs) within the MDR require a much more detailed and comprehensive MDR dossier, which is finally assessed by a notified body. A notified body is accredited by a national competent authority and therefore has a role similar to that of a health authority.

SCHOTT Pharma helps customers prepare for the Notified Body Opinion by providing customized dossier packages that cover the device part at the expected level of detail.

SCHOTT Pharma: MDR dossiers for customers' NBO success

Annex I of the Medical Device Registration dossier packages must describe both the medical device part and the containment system, and include a detailed assessment of the GSPRs. This approach to content selection and documentation has been verified based on in-depth experience of interactions with several notified bodies.

Based on this content selection, SCHOTT Pharma can prepare dossier packages that are customized to your specific combination of application and containment system. These dossier packages comprise specifications, raw material compliance, system compliance, product risk reports, production site compliance, process validation, and batch certification.

Our regulatory team collaborates with a number of notified bodies. This enables the direct exchange of confidential details under NDA with notified bodies to support the success of Notified Body Opinion applications.

World map with countries of the medical device regulation dossier highlighted in blue

A single, complete dossier for Medical Device Registration

Our MDR dossier packages cover the complete containment system as supplied by SCHOTT Pharma. These MDR dossier packages include all relevant compliance documentation for every aspect of containment systems and their related components.
Request MDR Dossier
Icon Superior reliability

Full system coverage- Registrations include all aspects of containment systems and their components (e.g. elastomers)

icon reduced complexity

Reduced complexity- Our MDRs enable both registration types: drug product or medical device registration.

Icon apply

Easy access- Online form enables easy access and ensures fast LoA availability in 2 - 3 weeks.

Icon No Registration

Always up-to-date- Document maintenance in eCTD format ensures full change control.

Request customized documents

If you need documentation that exceeds the MDR dossier content, please contact us.

Customized document by SCHOTT Pharma

Medical Device Registration dossier: How to proceed

MDR dossier packages are specific to your combination of product and country of interest. SCHOTT Pharma’s experts are ready to compile these documentation packages upon request.

Icon apply

1. Request dossier package

Please use the online form to transfer your product details and other information to receive a proposal including timeline information.

Icon pharma analytics study proposal

2. Request additional documentation

If you need documentation that exceeds the MDR dossier package’s content, please use the online form to receive a proposal including timeline.

Icon Documentation regulatory

3. Receive dossier package

After proposal acceptance, our regulatory expert team will complete your documentation package via a secured data exchange link.

Get in touch

Dr. Frank Hoffmann-Geim

Dr. Frank Hoffmann-Geim

Director Regulatory Affairs

* Field is required

SCHOTT Pharma will use your data only for reacting to your inquiry. Find more information about processing your personal data in SCHOTT Pharma’s data privacy policy


I agree that SCHOTT Pharma AG & Co. KGaA may send me e-mails with information on products and services of SCHOTT Pharma. My data will not be passed on to third parties. After registration, I can revoke my consent at any time at the SCHOTT Subscription Center following the link in each email footer.